Skip to main
INDV

Indivior PLC (INDV) Stock Forecast & Price Target

Indivior PLC (INDV) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Indivior PLC reported a substantial growth in its Sublocade treatment, with approximately 171,500 patients in 3Q25, reflecting an 8% increase compared to 3Q24, and an increase in prescribers by 11%. The company has raised its worldwide sales guidance for Sublocade to approximately $825M-$845M, indicating a robust annual growth rate of around 10% at the midpoint. Additionally, the overall sales for Indivior grew by approximately 14% in 3Q25 versus the same quarter in the previous year, positioning the company favorably amid increasing public awareness and acceptance of medication-assisted treatments (MATs).

Bears say

Indivior PLC faces a challenging outlook primarily due to the anticipated decline in revenue from Suboxone, driven by generic competition, which threatens to erode a significant portion of its income. Although there is potential for growth from Sublocade, it is still early in its commercial lifecycle, raising concerns about its ability to fully offset the revenue loss from Suboxone. Additionally, projected high levels of selling, general, and administrative (SG&A) expenses, estimated to be around 45% of revenue in 2026, may further strain the company's profitability amidst these revenue pressures.

Indivior PLC (INDV) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Indivior PLC and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Indivior PLC (INDV) Forecast

Analysts have given Indivior PLC (INDV) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Indivior PLC (INDV) has a Strong Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Indivior PLC (INDV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.